Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Pagès

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Oncotarget|December 6, 2018
Correction: The path to « the Golden Age » for the treatment of metastatic renal cell carcinomaGilles Pagès
Journal of Cellular Physiology|August 10, 2007
Sp3-mediated VEGF regulation is dependent on phosphorylation by extra-cellular signals regulated kinases (Erk)Gilles Pagès
Cancers|April 3, 2020
Metastatic Heterogeneity of Breast Cancer: Companion and Theranostic Approach in Nuclear MedicineChristopher Montemagno, Gilles Pagès
World Journal of Clinical Oncology|April 26, 2017
Targeted therapies in breast cancer: New challenges to fight against resistanceViviana Masoud, Gilles Pagès
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|April 5, 2014
Control of pro-angiogenic cytokine mRNA half-life in cancer: the role of AU-rich elements and associated proteinsPaola Griseri, Gilles Pagès
Frontiers in Cell and Developmental Biology|August 9, 2020
Neuropilins, as Relevant Oncology Target: Their Role in the Tumoral MicroenvironmentAurore Dumond, Gilles Pagès
Frontiers in Cell and Developmental Biology|August 11, 2020
Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the DrugsChristopher Montemagno, Gilles Pagès
Methods in Molecular Biology (Clifton, N.J.)|August 20, 2015
VEGF Splicing and the Role of VEGF Splice Variants: From Physiological-Pathological Conditions to Specific Pre-mRNA SplicingMélanie Guyot, Gilles Pagès
Journal De La Societe De Biologie|June 17, 2009
[The vascular endothelial growth factor (VEGF): a model of gene regulation and a marker of tumour aggressiveness. An obvious therapeutic target?]Renaud Grépin, Gilles Pagès
Biochimie|March 20, 2013
Mechanisms of resistance to anti-angiogenesis therapiesSandy Giuliano, Gilles Pagès
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Oncotarget|December 6, 2018
Correction: The path to « the Golden Age » for the treatment of metastatic renal cell carcinomaGilles Pagès
Journal of Cellular Physiology|August 10, 2007
Sp3-mediated VEGF regulation is dependent on phosphorylation by extra-cellular signals regulated kinases (Erk)Gilles Pagès
Cancers|April 3, 2020
Metastatic Heterogeneity of Breast Cancer: Companion and Theranostic Approach in Nuclear MedicineChristopher Montemagno, Gilles Pagès
World Journal of Clinical Oncology|April 26, 2017
Targeted therapies in breast cancer: New challenges to fight against resistanceViviana Masoud, Gilles Pagès
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|April 5, 2014
Control of pro-angiogenic cytokine mRNA half-life in cancer: the role of AU-rich elements and associated proteinsPaola Griseri, Gilles Pagès
Frontiers in Cell and Developmental Biology|August 9, 2020
Neuropilins, as Relevant Oncology Target: Their Role in the Tumoral MicroenvironmentAurore Dumond, Gilles Pagès
Frontiers in Cell and Developmental Biology|August 11, 2020
Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the DrugsChristopher Montemagno, Gilles Pagès
Methods in Molecular Biology (Clifton, N.J.)|August 20, 2015
VEGF Splicing and the Role of VEGF Splice Variants: From Physiological-Pathological Conditions to Specific Pre-mRNA SplicingMélanie Guyot, Gilles Pagès
Journal De La Societe De Biologie|June 17, 2009
[The vascular endothelial growth factor (VEGF): a model of gene regulation and a marker of tumour aggressiveness. An obvious therapeutic target?]Renaud Grépin, Gilles Pagès
Biochimie|March 20, 2013
Mechanisms of resistance to anti-angiogenesis therapiesSandy Giuliano, Gilles Pagès
Pageof 14